AGP Executive Report
Last update: 37 minutes agoEbola Vaccine Logistics: DR Congo received 16,520 doses of Merck’s Ervebo vaccine in Kinshasa, with more shipments expected, as the country battles its deadliest Ebola outbreak on record. Strain Challenge: Ervebo is approved for the Zaire strain, while the current outbreak is driven by the Bundibugyo strain; WHO says protection is still uncertain, so 20,000 doses are earmarked for a Phase 3 trial and 50,000 for frontline and health workers. Surveillance Push: Africa CDC warns the official case count may reflect only 30–40% of infections, estimating the outbreak could be 10,000–15,000 cases, prompting DR Congo to launch “Congo River Without Ebola” to tighten checks at ports and along river routes. Capital Risk Management: Health teams are stepping up screening for people arriving from affected areas near Kinshasa, where officials fear the virus could spread despite no cases reported so far. Frontline Strain: Health workers describe fear, burnout, and unpaid wages while treating patients, underscoring how staffing and support gaps are complicating the response.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.